Alkane Resources Ltd (ASX:ALK) continues to demonstrate that its extensive landholding at the Northern Molong Porphyry Project (NMPP) in Central West New South Wales has the potential to be a large, tier-one gold-copper project.
Further very broad mineralised gold-copper intersections have been returned from ongoing drilling at prospects in the region outside the Boda deposit’s inferred resource of 5.2 million ounces of gold and 900,000 tonnes of copper.
Jindalee Resources Ltd (ASX:JRL) has fielded several shallow intercepts of high-grade lithium mineralisation, generated in an infill drilling program designed to improve confidence in the McDermitt Lithium Project’s resource estimate.
Situated in Oregon, US, McDermitt already holds a JORC-compliant resource estimate of 1.82 billion tonnes at 1,370 parts per million lithium for 13.3 million tonnes of lithium carbonate equivalent.
G Mining Ventures Corp (TSX-V:GMIN, OTCQX:GMINF) is showing signs of having a solid project with continuous mineralization at its flagship Tocantinzinho (TZ) project in Brazil, according to seven financial industry analysts.
G Mining previously announced that the latest results confirm higher-grade gold in the main pit area of TZ and increased the extent of the area that would be mined during pre-production of the largest known gold deposit in the Tapajos province.
Silver Range Resources Ltd (TSX-V:SNG, OTC:SLRRF) said its partner Silver47 Exploration Corp has found promising grams per ton of silver at the Silver Matt site of its Michelle project in Yukon.
All five holes intersected oxide-sulphide mineralization, the company said.
American Resources Corporation (NASDAQ:AREC) announced that it has been approved by the Mine Safety and Health Administration for a deep cut plan at its Carnegie 1 mine in Kentucky, USA.
The company said the enhanced mine plan enables 30% additional production per shift and reduces maintenance expenses at the mine.
Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said it has entered into an investigator-initiated clinical trial agreement (CTA) with Yale University for the investigation of multiple intravenous doses of N,N-Dimethyltryptamine (DMT) for the treatment of depression.
The trial's principal investigator is Dr. Deepak Cyril D'Souza, professor of psychiatry and director of the Schizophrenia Neuropharmacology Research Group at the Yale University School of Medicine, an experienced researcher with DMT and other controlled substances.
88 Energy Ltd (AIM:88E, ASX:88E, OTC:EEENF) has detailed plans for the Hickory-1 exploration well, in Alaska, where drilling is slated next year.
The company, in its latest quarterly activities report to the Australian Securities Exchange, highlighted that the Hickory well will be drilled vertically, down to a depth of around 12,500 feet. It is intended to test four reservoirs on Alaska's North Slope
Zephyr Energy PLC (AIM:ZPHR, OTCQB:ZPHRF) told investors it has signed a cooperation agreement with Kirkwood Oil and Gas covering data sharing and joint drilling in the Paradox basin, Utah.
The company, in a statement, additionally said that it remains confident that it can start its planned drill programmes in Utah in the near term. Zephyr noted that has completed all preparations to begin drilling the fully-funded State 36-2 LNW-CC well and it is awaiting a final Federal drilling permit – such approvals have slowed markedly across the entire US domestic oil and gas industry, it added.
Rainbow Rare Earths Ltd (LSE:RBW, OTC:RBWRF) has posted full-year results highlighting the recent completion of its robust preliminary economic assessment (PEA) for the Phalaborwa rare earths project in South Africa.
During the period, the company noted that it made significant progress on its Phalaborwa asset. This included the recent publication of the PEA, which detailed robust economics and the significant opportunity provided by this project to provide near-term production of rare earth oxides.
ANGLE PLC (AIM:AGL, OTCQX:ANPCY), a world-leading liquid biopsy company, said it has presented results from a proof of concept study at the International Society of Liquid Biopsy meeting held in Miami, Florida on October 20-22, 2022.
The company noted that the study demonstrated that both circulating tumour cells (CTCs) and cell-free circulating tumour DNA (ctDNA) can be analysed from a single blood sample. The results show that removal of plasma from blood samples for ctDNA analysis does not impact on the number or quality of CTCs which can be successfully isolated from the same sample using the company's Parsortix system, it added.
Kenorland Minerals Ltd (TSX-V:KLD) said it its board of directors has accepted the resignation of Francis MacDonald as president of the company. MacDonald has decided to pursue other opportunities and the company said its board wishes him well with his future endeavours. MacDonald will continue to support the Company through a lead technical advisory role. Zach Flood, CEO and director of the company, will assume the role of president. Flood, commented, "Francis, myself, and two other co-founders, Scott Smits, Vice President of Exploration, and Dave Stevenson, Chief Geoscientist, created Kenorland in 2016 with the vision to become one of the leading exploration companies in the business. Together, along with the rest of the Kenorland team and with strong support from our shareholders, we've accomplished that goal, and while there is still immense value for us to create through continued exploration and discovery, we support Francis' decision to pursue other opportunities. On behalf of Kenorland, we thank Francis for his significant contributions and wish him all the best on this next chapter of his career. At the same time, we look forward to his continued involvement in the company as a lead technical advisor."
Africa Oil Corp (TSX:AOI) has said it repurchased a total of 1,604,350 of its common shares during the period of October 17, 2022, to October 21, 2022, under a previously announced share buyback program. During the period dated October 17, 2022, to October 21, 2022, the company repurchased 834,350 Africa Oil common shares on the TSX and/or alternative Canadian trading systems. The repurchases were carried out by Scotia Capital on behalf of the company. During the same period, the company repurchased 770,000 Africa Oil common shares on Nasdaq Stockholm, and these repurchases were carried out by Pareto Securities on behalf of the company. All common shares repurchased by Africa Oil under the share buyback program will be cancelled. During the period dated October 17, 2022, to October 21, 2022, the company cancelled 4,708,050 common shares repurchased under the share buyback program. Since September 27, 2022, up to and including October 21, 2022, a total of 9,674,660 Africa Oil common shares have been repurchased under the share repurchase program through the facilities of the TSX, Nasdaq Stockholm and/or alternative Canadian trading systems. A maximum of 40,482,356 Africa Oil common shares may be repurchased under the share buyback program through the facilities of the TSX, Nasdaq Stockholm and/or alternative Canadian trading systems over the period of twelve months commencing September 27, 2022 and ending September 26, 2023, or until such earlier date as the share repurchase program is completed or terminated by the company.
KULR Technology Group Inc (NYSE:KULR) announced it will hold a conference call on Wednesday, November 9, 2022 at 4:30 p.m. ET (1:30 p.m. PT) to discuss its financial results for the third quarter ended September 30, 2022. Financial results will be issued in a press release prior to the call. KULR management will host the conference call, followed by a question-and-answer period. U.S. dial-in: 855-459-0165; Access Code: 361411. A webcast will be accessible here.
Burcon NutraScience Corporation, a Vancouver-based plant-based foods and beverage company, announced that it will hold an investor conference call and webcast at 5 pm ET on November 7 to discuss its financial results for the fiscal second quarter ended September 30. Interested parties can dial in toll-free in North America at 1-855-327-6837 or dial in internationally at 1-631-891-4304.
Vyant Bio Inc announced that it will be presenting at the LD Micro Main Event XV at 4:30 pm PT (7:30 pm ET) on October 26 at the Luxe Sunset Boulevard Hotel in Los Angeles. Vyant's CEO Jay Roberts will discuss key milestones and achievements on the scientific, business, and strategic fronts. Vyant management will also be available for one-on-one meetings with interested parties at the conference all day on October 26.